2023 Reimbursement Guide for Physicians and Facilities

The Intracept Procedure is supported with Level l clinical evidence, has 510(k) Clearance, and is commercially available in the United States. For more information on the reimbursement support, please contact Relievant’s reimbursement team at reimbursement@relievant.com.

Relievant Medsystems, Inc. is pleased to provide general information on coding, coverage and payment. This information is not intended to be legal or financial advice. Nothing stated above should be construed as a guarantee by Relievant of coverage or payment for Intracept Procedures. Nothing should be viewed as an instruction to use a particular code or influence levels of payment. Providers are responsible for exercising their independent clinical judgment and reporting the codes that accurately reflect the patient’s condition and the services rendered and submit bills consistent with the patient’s insurer’s requirements. Reimbursement changes annually. This information is accurate as of January 1, 2023. Providers are advised to consult with the applicable payer or the specialty society or legal counsel for any coding, payment or billing related issues.